Volume 1, Issue 3, September 2015, Pages: 34-37
Received: Jan. 12, 2016;
Accepted: Jan. 20, 2016;
Published: Feb. 4, 2016
Views 4365 Downloads 164
Shen Tao, Chinese Academy of Sciences Key Laboratory of Brain Function and Disease, School of Life Sciences, University of Science and Technology of China, Hefei, China
Zhang Xiu-Lei, Chinese Academy of Sciences Key Laboratory of Brain Function and Disease, School of Life Sciences, University of Science and Technology of China, Hefei, China
Liang Xiao-Lin, Chinese Academy of Sciences Key Laboratory of Brain Function and Disease, School of Life Sciences, University of Science and Technology of China, Hefei, China
Min Sai-Nan, Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China
Guo Yu-Zhu, Chinese Academy of Sciences Key Laboratory of Brain Function and Disease, School of Life Sciences, University of Science and Technology of China, Hefei, China
Wang Xiang-Ting, Chinese Academy of Sciences Key Laboratory of Brain Function and Disease, School of Life Sciences, University of Science and Technology of China, Hefei, China
Long noncoding RNAs (lncRNAs) are a class of regulatory RNA molecules that are no shorter than 200 nucleotides in length with rare protein encoding capacity. It is widely accepted nowadays that lncRNAs play important roles in tumorigenesis and related events. Recently, some comprehensive investigations and major advances of lncRNAs have also been made in other fields including cardiovascular and central nervous system. Here, we will overview the recent progress of lncRNAs, particularly in those fields other than cancer biology, from which big breakthroughs or milestone works have been made.
Recent Progresses of Long Noncoding RNA, Biomedical Sciences.
Vol. 1, No. 3,
2015, pp. 34-37.
Yan X, Hu Z, Feng Y, et al. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. [J]. Cancer Cell, 2015, 28(4): 529-540.
Quinn J J, Chang H Y. Unique features of long non-coding RNA biogenesis and function. [J]. Nature Reviews Genetics, 2016.
Wang X, Arai S, Song X, et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription [J]. Nature, 2008, 454(7200): 126-130.
Yang F, Deng X, Ma W, et al. The lncRNA Firre anchors the inactive X chromosome to the nucleolus by binding CTCF and maintains H3K27me3 methylation. [J]. Genome Biology, 2015, 16(1): 1-17.
Brannan C I, Dees E C, Ingram R S, et al. The product of the H19 gene may function as an RNA. [J]. Molecular & Cellular Biology, 1990, 10(1): 28–36.
Brown C J, Ballabio A, Rupert J L, et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. [J]. Nature, 1991, 349 (6304): 38-44.
Marahrens Y, Panning B, Dausman J, et al. Xist-deficient mice are defective in dosage compensation but not spermatogenesis. [J]. Genes & Development, 1997, 11(2): 156-66.
Csankovszki G, Panning B, Bates B, et al. Conditional deletion of Xist disrupts histone macroH2A localization but not maintenance of X inactivation. [J]. Nature Genetics, 1999, 22(4): 323-324.
Leighton P A, Ingram R S, Eggenschwiler J, et al. Disruption of imprinting caused by deletion of the H19 gene region in mice. [J]. Nature, 1995, 375(6526): págs. 34-39.
Leighton P A, Saam J R, Ingram R S, et al. An enhancer deletion affects both H19 and Igf2 expression. [J]. Genes & Development, 1995, 9(17): 2079-89.
Ripoche M A, Kress C, Poirier F, et al. Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. [J]. Genes & Development, 1997, 11(12): 1596-1604.
Brannan C I, Dees E C, Ingram R S, et al. The product of the H19 gene may function as an RNA. [J]. Molecular & Cellular Biology, 1990, 10 (1): 28–36.
Zhong C, Yin Q, Xie Z, et al. CRISPR-Cas9-Mediated Genetic Screening in Mice with Haploid Embryonic Stem Cells Carrying a Guide RNA Library[J]. Cell Stem Cell, 2015, 17(2): 247.
Li W, Shuai L, Wan H, et al. Androgenetic haploid embryonic stem cells produce live transgenic mice. [J]. Nature, 2012, 490(7420): 407-11.
Sauvageau M, Goff L A, Lodato S, et al. Multiple knockout mouse models reveal lincRNAs are required for life and brain development. [J]. Elife, 2013, 2(12): e01749-e01749.
Grote P, Wittler L, Hendrix D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. [J]. Developmental cell, 2013, 24(2): 206-214.
Klattenhoff C A, Scheuermann J C, Surface L E, et al. Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment. [J]. Cell, 2013, 152(3): 570–583.
Caretti G, Schiltz R L, Dilworth F J, et al. The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation. [J]. Developmental Cell, 2006, 11(4): 547-560.
Hubé F, Velasco G, Rollin J, et al. Steroid receptor RNA activator protein binds to and counteracts SRA RNA-mediated activation of MyoD and muscle differentiation. [J]. Nucleic acids research, 2011, 39(2): 513-525.
Scheuermann J C, Boyer L A. Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease. [J]. Embo Journal, 2013, 32(13): 1805–1816.
Li K, Blum Y, Verma A, et al. A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. [J]. Blood, 2010, 115(1): 133-139.
Schmaier A H, Merkulova A, LaRusch G A, et al. UPAR's domain 2 regulates single chain urokinase-mediated angiogenesis through beta-1-integrins and VEGFR2[C]//JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL, 2013, 11: 85-85.
Schonrock N, Harvey R P, Mattick J S. Long noncoding RNAs in cardiac development and pathophysiology. [J]. Circulation research, 2012, 111(10): 1349-1362.
Mattick J S. A new paradigm for developmental biology. [J]. Journal of Experimental Biology, 2007, 210(Pt 9): 1526-1547.
Laurent G S, Wahlestedt C. Noncoding RNAs: couplers of analog and digital information in nervous system function? [J]. Trends in neurosciences, 2007, 30(12): 612-621.
Yao P, Lin P, Gokoolparsadh A, et al. Coexpression networks identify brain region–specific enhancer RNAs in the human brain. [J]. Nature Neuroscience, 2015, 18(8): 1168-1174.
Liu T, Huang Y, Chen J, et al. Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1 AS expression [J]. Molecular medicine reports, 2014, 10(3): 1275-1281.
Mus E, Hof P R, Tiedge H. Dendritic BC200 RNA in aging and in Alzheimer's disease. [J]. Proceedings of the National Academy of Sciences, 2007, 104 (25): 10679-10684.
Lukiw W J, Handley P, Wong L, et al. BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD). [J]. Neurochemical Research, 1992, 17(6): 591-597.
Arisi I, D'Onofrio M, Brandi R, et al. Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection. [J]. Journal of Alzheimers Disease Jad, 2011, 24 (4): 721-38.
Parenti R, Paratore S, Torrisi A, et al. A natural antisense transcript against Rad18, specifically expressed in neurons and upregulated during beta-amyloid-induced apoptosis. [J]. European Journal of Neuroscience, 2007, 26(9): 2444-57.
Massone S, Vassallo I, Fiorino G, et al. 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. [J]. Neurobiology of Disease, 2011, 41(2): 308–317.
Airavaara M, Pletnikova O, Doyle M E, et al. Identification of novel GDNF isoforms and cis-antisense GDNFOS gene and their regulation in human middle temporal gyrus of Alzheimer disease. [J]. Journal of Biological Chemistry, 2011, 286(52): 45093-45102.